Gastrointestinal symptoms in pediatric patients with type 1 diabetes mellitus

Suna Selbuz1, Ayşe Derya Buluş1

  • 1Keçiören Research and Training Hospital, Pediatric Endocrinology, Ankara, Turkey.

Insights

Gastrointestinal symptoms like reflux and abdominal pain are common in children with type 1 diabetes mellitus (T1DM). Poor glycemic control significantly increases the prevalence of these digestive issues.

Area of Science:

  • Pediatric Gastroenterology
  • Endocrinology
  • Clinical Research

Background:

  • Gastrointestinal (GI) symptoms are frequently observed in individuals with diabetes.
  • Limited research exists on GI issues in pediatric patients with type 1 diabetes mellitus (T1DM).

Purpose of the Study:

  • To determine the prevalence of GI symptoms in pediatric T1DM patients.
  • To investigate the correlation between GI symptoms, diabetes duration, and glycemic control.

Main Methods:

  • 137 pediatric T1DM patients were assessed for demographic features and GI symptoms.
  • Laboratory tests including HbA1c, and stool examinations were performed.
  • Endoscopy and gastric emptying scintigraphy were utilized for complex cases.

Main Results:

  • 54% of patients reported at least one GI complaint, with gastroesophageal reflux (32.8%) and abdominal pain (18%) being most common.
  • Reflux and dyspeptic symptoms were significantly more prevalent in patients with poor or very poor glycemic control (p=0.003 and p=0.004).

Conclusions:

  • Diabetes mellitus can impact the entire GI tract, leading to frequent GI symptoms in pediatric populations.
  • Routine evaluation for GI symptoms is recommended for pediatric patients with T1DM.

Related Concept Videos

Diabetes: Symptoms, Diagnosis, and Complications01:15

Diabetes: Symptoms, Diagnosis, and Complications

For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
1.9K
Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
4.7K
Other Disorders of Digestive System01:30

Other Disorders of Digestive System

The gastrointestinal tract is susceptible to various disorders. If the lower esophageal sphincter is damaged, stomach acid can flow back into the esophagus, causing irritation and inflammation of the lining. This condition is called gastroesophageal reflux disease (known as heartburn) and may cause chest pain and difficulty swallowing. In the stomach, prolonged use of nonsteroidal anti-inflammatory drugs like aspirin, chronic alcohol consumption, bacterial infections such as Helicobacter...
1.3K
Insulin: Dosing Regimen and Adverse Effects01:16

Insulin: Dosing Regimen and Adverse Effects

Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
610
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy01:30

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
580
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
4.2K